Research.Patient.info
Relapsed/Refractory Non-Hodgkin Lymphoma research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE1, PHASE2
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
This study is looking into a new treatment, BMS-986458, both on its own and mixed with other anti-lymphoma medicines. It's for people in the UK with non-Hodgkin lymphoma that has come back or not responded to previous treatments. We want to see if it's safe and how well it works.
United States · Chile · China - ongoing, recruitingHuman Pharmacology (Phase I)- Other
Study of safety and preliminary efficacy of VAY736 given alone or in combination with other antineoplastic agents in patients with NHL
This study is looking at a new medicine called VAY736. It’s for adults with a type of blood cancer called Non-Hodgkin Lymphoma that has come back or hasn’t responded to previous treatments. Researchers want to see if it’s safe and how well it works, either alone or with other cancer drugs.
Germany · Italy · Spain